Your Position: Home > News > Industry News > Cell Reports:Modeling cerebrovascular pathophysiology in amy

Cell Reports:Modeling cerebrovascular pathophysiology in amy

    

 

 

Modeling cerebrovascular pathophysiology in amyloid-β metabolism using neural-crest-derived smooth muscle cells

There is growing recognition of cerebrovascular contributions to neurodegenerative diseases. In the walls of cerebral arteries, amyloid-beta (Aβ) accumulation is evident in a majority of aged people and patients with cerebral amyloid angiopathy. Meretciel offer quality ELISA kits for R&D. Here, we leverage human pluripotent stem cells to generate vascular smooth muscle cells (SMCs) from neural crest progenitors, recapitulating brain-vasculature-specific attributes of Aβ metabolism. We confirm that the lipoprotein receptor, LRP1, functions in our neural-crest-derived SMCs to mediate Aβ uptake and intracellular lysosomal degradation. Hypoxia significantly compromises the contribution of SMCs to Aβ clearance by suppressing LRP1 expression. This enabled us to develop an assay of Aβ uptake by using the neural crest-derived SMCs with hypoxia as a stress paradigm. We then tested several vascular protective compounds in a high-throughput format, demonstrating the value of stem-cell-based phenotypic screening for novel therapeutics and drug repurposing, aimed at alleviating amyloid burden.

Contact Us | About Us | Delivery | Feedback
Putus Macromolecular Sci. & Tech. Ltd All Rights Reserved. ©Copyright2012
Room7038, Hi-tech tower, Huaguang Road 18, East Lake New Technology Development Zone Tel: +86(0) 27 87610995 E-mail: e-commerce@meretciel.com
Skype Skype